Eyal C. Attar - 08 May 2023 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Medical Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
08 May 2023
Net transactions value
-$4,012
Form type
4
Filing time
10 May 2023, 16:14:45 UTC
Previous filing
08 Feb 2023
Next filing
09 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability $4,012 -969 -1.8% $4.14 53,531 08 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").